| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Hsa_circ_0102533 acts as an oncogenic circRNA in NSCLC; its knockdown inhibits NSCLC cell proliferation and induces apoptosis. |
| Molecular mechanism: |
PCNX-originated hsa_circ_0102533 is involved in PCNX-mediated proliferation and apoptosis in lung cancer cells; microRNA sponge mechanism was not investigated. |
| Biological pathway or process: |
proliferation (promotes); apoptosis (inhibits) |
| Detected method: |
Q
M
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Microarray; RT-qPCR; Clinical Sample Validation; ROC Analysis; Transfection; CCK8; Annexin V/PI Flow Cytometry |
| Clinical significance: |
Hsa_circ_0102533 may serve as a blood-based early diagnostic biomarker for NSCLC detection; AUC was 0.744 for NSCLC patients versus healthy subjects, 0.774 for stage I-II NSCLC, and 0.728 for stage III-IV NSCLC. |
| Description: |
Hsa_circ_0102533 is up-regulated in NSCLC tumor tissues, whole blood, and NSCLC cell lines. It promotes NSCLC cell proliferation and suppresses apoptosis in vitro, and its blood expression shows diagnostic potential, especially for early-stage NSCLC. |
| Confidence score: |
0.7472 |